Literature DB >> 184552

Occurrence of primary hepatocellular cancer and peliosis hepatis after treatment with androgenic steroids.

M C Kew, B Van Coller, C M Prowse, B Skikne, J I Wolfsdorf, J Isdale, S Krawitz, H Altman, S E Levin, T H Bothwell.   

Abstract

Three patients are reported in whom treatment of Fanconi's anaemia with androgenic steroids was complicated by the development of either primary hepatocellular cancer (PHC) or peliosis hepatis. The first, a White woman aged 34 years, was found to have PHC after receiving first methyltestosterone and then oxymetholone for a total period of 7 years. She died 4 months after the diagnosis was made. The other 2 patients were White children who presented with peliosis hepatis after receiving methyltestosterone and oxymetholone for 8 years and oxymetholone for 5 years, respectively. Both died from their primary diseases shortly after oxymetholone treatment was discontinued. Possible pathogenic mechanisms involved in the development of these serious complications are discussed and the therapeutic dilemma raised by their occurrence is emphasised.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184552

Source DB:  PubMed          Journal:  S Afr Med J


  8 in total

1.  Peliosis hepatis. Its relationship to chronic alcoholism, aflatoxin B1, and carcinogenesis in male Holtzman rats.

Authors:  C L Mendenhall; A Chedid
Journal:  Dig Dis Sci       Date:  1980-08       Impact factor: 3.199

2.  Hepatic reactions to drugs.

Authors:  S Sherlock
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

Review 3.  Adverse effects of anabolic steroids.

Authors:  R C Hickson; K L Ball; M T Falduto
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

4.  Living related liver transplantation in an adult patient with hepatocellular adenoma and carcinoma 13 years after bone marrow transplantation for Fanconi anemia: A case report.

Authors:  Isabelle Colle; Geneviève Laureys; Sarah Raevens; Louis Libbrecht; Juliaan G Leroy; Koen Reyntjens; Anja Geerts; Xavier Rogiers; Roberto I Troisi; Holger Hoehn; Detlev Schindler; Helmut Hanenberg; Vincent De Wilde; Hans Van Vlierberghe
Journal:  Hepatol Res       Date:  2013-05-15       Impact factor: 4.288

5.  Androgen associated hepatocellular carcinoma with an aggressive course.

Authors:  D Gleeson; M J Newbould; P Taylor; R F McMahon; B C Leahy; T W Warnes
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

6.  Infantile peliosis hepatis. A case report.

Authors:  A Cragg; W Castaneda-Zuniga; G Lund; E Salomonowitz; K Amplatz
Journal:  Pediatr Radiol       Date:  1984

7.  [Approaches to a selective chemotherapy of hepatocellular carcinoma (author's transl)].

Authors:  J Pausch; A Holstege; D Keppler; W Gerok
Journal:  Klin Wochenschr       Date:  1981-06-15

Review 8.  Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States.

Authors:  Mark I Avigan; Robert P Mozersky; Leonard B Seeff
Journal:  Int J Mol Sci       Date:  2016-03-03       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.